Sequoia Financial Advisors LLC Has $360,000 Stake in Henry Schein Inc. (HSIC)
Sequoia Financial Advisors LLC maintained its stake in shares of Henry Schein Inc. (NASDAQ:HSIC) during the second quarter, Holdings Channel reports. The fund owned 2,037 shares of the company’s stock at the end of the second quarter. Sequoia Financial Advisors LLC’s holdings in Henry Schein were worth $360,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Quadrant Capital Group LLC boosted its stake in shares of Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares during the last quarter. Montag & Caldwell LLC boosted its stake in shares of Henry Schein by 0.3% in the second quarter. Montag & Caldwell LLC now owns 2,700 shares of the company’s stock worth $477,000 after buying an additional 7 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD boosted its stake in shares of Henry Schein by 0.9% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 6,312 shares of the company’s stock worth $1,115,000 after buying an additional 54 shares during the last quarter. Retirement Systems of Alabama boosted its stake in shares of Henry Schein by 0.3% in the second quarter. Retirement Systems of Alabama now owns 41,838 shares of the company’s stock worth $7,397,000 after buying an additional 105 shares during the last quarter. Finally, Shell Asset Management Co. boosted its stake in shares of Henry Schein by 0.3% in the second quarter. Shell Asset Management Co. now owns 53,488 shares of the company’s stock worth $9,457,000 after buying an additional 141 shares during the last quarter. 92.03% of the stock is currently owned by hedge funds and other institutional investors.
Henry Schein Inc. (NASDAQ:HSIC) traded up 0.09% on Tuesday, reaching $153.35. 594,601 shares of the company traded hands. The stock has a market capitalization of $12.54 billion, a price-to-earnings ratio of 25.98 and a beta of 1.05. The firm has a 50 day moving average price of $161.88 and a 200 day moving average price of $169.89. Henry Schein Inc. has a 52-week low of $142.64 and a 52-week high of $183.00.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. During the same period in the previous year, the business earned $1.46 earnings per share. Henry Schein’s revenue for the quarter was up 9.3% compared to the same quarter last year. Equities research analysts predict that Henry Schein Inc. will post $6.57 EPS for the current year.
A number of brokerages recently commented on HSIC. Zacks Investment Research cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday. Robert W. Baird cut shares of Henry Schein from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $176.00 to $164.00 in a research note on Friday. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target on the stock in a research note on Tuesday, October 11th. Finally, Bank of America Corp. assumed coverage on shares of Henry Schein in a research note on Monday, September 12th. They set a “buy” rating and a $185.00 price target on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $159.50.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the business’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the sale, the director now owns 13,715 shares in the company, valued at approximately $2,249,671.45. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.27% of the stock is currently owned by company insiders.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.